Relationship Between Cysteinyl-Leukotriene-1 Receptor and Human Transitional Cell Carcinoma in Bladder

Urology

Volumn 73, Issue 4, 2009, Pages 916-921

  Matsuyama, Masahide ^a   Funao, Kiyoaki ^a   Hayama, Takuma ^a   Tanaka, Tomoaki ^a   Kawahito, Yutaka ^b   Sano, Hajime ^c   Takemoto, Yoshiaki ^a   Nakatani, Tatsuya ^a   Yoshimura, Rikio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYSTEINYL LEUKOTRIENE 1 RECEPTOR; LEUKOTRIENE D4 RECEPTOR; MONTELUKAST; PROSTAGLANDIN SYNTHASE; RECEPTOR; UNCLASSIFIED DRUG;

ADVANCED CANCER; AGED; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; BLADDER; BLADDER CARCINOMA; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; HUMANS; RECEPTORS, LEUKOTRIENE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 63149103123     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.11.005     Document Type: Article

References (16)

1. Yoshimura R., Sano H., Mitsuhashi M., et al. Expression of cyclooxygenase-2 in patients with bladder carcinoma. J Urol 165 (2001) 1468-1472
2. Yoshimura R., Matsuyama M., Tsuchida K., et al. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 170 (2003) 1994-1999
3. Lynch K.R., O'Neill G.P., Liu G., et al. Characterization of human cysteinyl leukotroene CysLT1 receptor. Nature 399 (1999) 789-793
4. Ohd J.F., Wikstrom K., and Sjolander A. Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 119 (2000) 1007-1018
5. Nielsen C.K., Campbell J.I., Ohd J.F., et al. A novel localization of the G protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65 (2005) 732-742
6. Matsuyama M., Yoshimura R., Mitsuhashi M., et al. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncol Rep 14 (2005) 73-79
7. Matsuyama M., Yoshimura R., Mitsuhashi M., et al. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol 24 (2004) 821-827
8. Yoshimura R., Matsuyama M., Mitsuhashi M., et al. Relationship between lipoxygenase and human testicular cancer. Int J Mol Med 13 (2004) 389-393
9. Sano H., Hla T., Maier J.A.M., et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89 (1992) 97-108
10. Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 8 (2007) 2173-2187
11. Fitzgerald S.M., and Flinn S. Evaluating research studies using the analysis of variance (ANOVA): issues and interpretations. J Hand Ther 13 (2000) 56-60
12. Horwitz R.J., McGill K.A., and Busse W.W. The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med 157 (1998) 1363-1371
13. Wenzel S.E. New approaches to anti-inflammatory therapy for asthma. Am J Med 104 (1998) 287-300
14. Drazen J. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am J Respir Crit Care Med 157 (1998) 233-237
15. Matsuyama M., Yoshimura R., Tsuchida K., et al. Lipoxygenase inhibitors prevent urological cancer cell growth. Int J Mol Med 13 (2004) 665-668
16. 1R antagonist inhibits prostate cancer cell growth through apoptosis. Oncol Rep 18 (2007) 99-104